Sign In
Buy RYTM
$99.25
-6.49 (-6.14%)
At Close: Jul 31, 2026
Rhythm Pharmaceuticals to Present at Canaccord Genuity 42nd Annual Growth Conference
08:00am, Wednesday, 03'rd Aug 2022
BOSTON, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families liv
Why Rhythm Pharmaceuticals Stock Is Rocketing Higher Today
07:51pm, Tuesday, 02'nd Aug 2022 The Motley Fool
The biotech's second-quarter earnings report is a big hit with shareholders.
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session
04:41pm, Tuesday, 02'nd Aug 2022 Benzinga
Gainers
AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.
Applied DNA Sciences, Inc. (NASDAQ: APDN) gained 166% to $1.8801
Why Rhythm Pharmaceuticals Stock Is Rocketing Higher Today
03:51pm, Tuesday, 02'nd Aug 2022
The biotech's second-quarter earnings report is a big hit with shareholders.
Why U.S. Stocks Are Trading Lower; Job Openings Drop To This Level In June
02:34pm, Tuesday, 02'nd Aug 2022 Benzinga
U.S. stocks traded lower this morning, with the Dow Jones falling more than 250 points on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.87% to 32,511.89 while the NASDAQ fell 0.
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Lags Revenue Estimates
12:25pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Rhythm Pharmaceuticals, Inc. (RYTM) delivered earnings and revenue surprises of -12.66% and 58.13%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the
Rhythm Pharmaceuticals, Inc. (RYTM) CEO David Meeker on Q2 2022 Results - Earnings Call Transcript
11:23am, Tuesday, 02'nd Aug 2022
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM ) Q2 2022 Results Earnings Conference Call August 2, 2022 8:00 AM ET Company Participants David Connolly - Investor Relations and Corporate Communications Dav
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Lags Revenue Estimates
09:50am, Tuesday, 02'nd Aug 2022
Rhythm Pharmaceuticals, Inc. (RYTM) delivered earnings and revenue surprises of -12.66% and 58.13%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the
Why Shares Of Rhythm Pharmaceuticals Are Soaring
10:48am, Wednesday, 20'th Jul 2022
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) shares are trading higher after the French National Agency for Medicines and Health Products Safety and Haute Autorité de santé granted pre-marketing auth
Rhythm (RYTM) Surges on Upbeat Data on Lead Product Candidate
01:51pm, Wednesday, 13'th Jul 2022
Rhythm Pharmaceuticals (RYTM) reports favorable data from a mid-stage study evaluating the efficacy of setmelanotide, its MC4R agonist, for treating hypothalamic obesity.
5 Penny Stocks To Watch With High Short Interest, Are They A Buy Now?
11:03am, Friday, 17'th Jun 2022
Penny stocks are red hot right now if you know where to… The post 5 Penny Stocks To Watch With High Short Interest, Are They A Buy Now? appeared first on Penny Stocks to Buy, Picks, News and Informa
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
05:11pm, Friday, 03'rd Jun 2022
Biotech investors stand to make a windfall if they make calculated bets by thoroughly researching on key catalysts that could move the stocks in a big way. The post 6 Biotech Stocks to Buy Now Ahead o
Rhythm Pharmaceuticals, Inc. (RYTM) CEO David Meeker on Q1 2022 Results - Earnings Call Transcript
02:47pm, Tuesday, 03'rd May 2022
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM ) Q1 2022 Earnings Conference Call May 3, 2022 8:30 AM ET Company Participants David Connolly - Investor Relations and Corporate Communications David Meeker -
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates
09:47am, Tuesday, 03'rd May 2022
Rhythm Pharmaceuticals, Inc. (RYTM) delivered earnings and revenue surprises of -7.14% and 38.86%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the
Rhythm Pharmaceuticals to Report First Quarter 2022 Financial Results on Tuesday, May 3, 2022
08:00am, Tuesday, 26'th Apr 2022
BOSTON, April 26, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genet
